Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 19 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 19 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Stop signs graphic

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

NIH Trial Testing Current Drugs to Treat Covid-19

Medical gear

A clinical trial is planned to assess two drugs designed for other medical conditions as treatments for Covid-19 infections. . . . → Read More: NIH Trial Testing Current Drugs to Treat Covid-19

NIH Trials Testing Covid-19 Blood Clot Therapies

Heart, circulation system

National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections. . . . → Read More: NIH Trials Testing Covid-19 Blood Clot Therapies

Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Syrine ingloved hand

In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Brain Signal Synchronization Device in Development

Brain activity graphic

An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development

NIH Nixes Convalescent Plasma Covid-19 Therapy

Donated plasma

An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections. . . . → Read More: NIH Nixes Convalescent Plasma Covid-19 Therapy

Small Biz Grant Advances Neuro Protection Drugs

Neurons

An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease. . . . → Read More: Small Biz Grant Advances Neuro Protection Drugs

Muti-Focus Contact Lenses Slow Children’s Myopia

Contact lens

Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia

Covid-19 Vaccines, Therapies – 10 August 2020

Covid-19 vaccine and therapy tracker

Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020

NIH Begins Covid-19 Antibody Trials

Global Covid-19

National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials